Tweet
IHS Global Insight
January 6, 2015
Armenia's Arpimed receives GMP certification
by Kavita Rainova
Armenian pharmaceutical company Arpimed has received the European good
manufacturing practice (GMP) certification, reportsPharmvestnik,
citing News.am. Arpimed's director Vachagan Ghazaryan noted that
approximately 45% of the company's production is currently exported to
countries including Belarus, Georgia, Kazakhstan, Kyrgyzstan,
Turkmenistan, Ukraine, and Uzbekistan.
Significance:Although the fact that Arpimed received the GMP
certification marks the second Armenian company, of the 18 companies
on the domestic market, to receive the GMP-compliance certification
(the first being Likvor), it is noteworthy that in late 2012, it was
announced that GMP compliance was to be put in place in the country
from the beginning of 2013 (seeArmenia: 7 November 2012:). The
development nevertheless is in line with the government's intent to
increase pharmaceutical exports, with the pharmaceutical industry
being one of the 11 industries included in the country's strategies
for export-oriented industry development (seeArmenia: 19 September
2013:). GMP compliance would potentially enable access of Armenian
companies' products to the European market.
January 6, 2015
Armenia's Arpimed receives GMP certification
by Kavita Rainova
Armenian pharmaceutical company Arpimed has received the European good
manufacturing practice (GMP) certification, reportsPharmvestnik,
citing News.am. Arpimed's director Vachagan Ghazaryan noted that
approximately 45% of the company's production is currently exported to
countries including Belarus, Georgia, Kazakhstan, Kyrgyzstan,
Turkmenistan, Ukraine, and Uzbekistan.
Significance:Although the fact that Arpimed received the GMP
certification marks the second Armenian company, of the 18 companies
on the domestic market, to receive the GMP-compliance certification
(the first being Likvor), it is noteworthy that in late 2012, it was
announced that GMP compliance was to be put in place in the country
from the beginning of 2013 (seeArmenia: 7 November 2012:). The
development nevertheless is in line with the government's intent to
increase pharmaceutical exports, with the pharmaceutical industry
being one of the 11 industries included in the country's strategies
for export-oriented industry development (seeArmenia: 19 September
2013:). GMP compliance would potentially enable access of Armenian
companies' products to the European market.